IS

Iftach Seri

Director Director DIN 07977673
DIN 07977673 First appointment Nov 2017 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Nov 2017
Shareholding value •••• Premium profile

About Iftach Seri

Data last updated:

Iftach Seri was a Director at Vanamali Organics Private Limited (2021–2022) and Director at Monolom India Pharma Private Limited (2017–2022). The companies operate in Chemicals and Materials and Pharma.

DIN 07977673
Primary Designation Director
Industry Chemicals and Materials
First Appointment 20 Nov 2017

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vanamali Organics Private Limited U24232TG2013PTC086144
Director16 Apr 20212013₹79.39 Cr (FY 2025)Active
Monolom India Pharma Private Limited U24303PN2017FTC188118
Director20 Nov 20172017₹18.17 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Vanamali Organics Private Limited
Monolom India Pharma Private Limited
Premium access

Shareholding and investment profile for Iftach Seri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Iftach Seri

Iftach Seri was first appointed on 20 Nov 2017 as Director at Monolom India Pharma Private Limited. The most recent appointment on record is 16 Apr 2021 at Vanamali Organics Private Limited.

Iftach Seri held 2 earlier board appointments: Vanamali Organics Private Limited (Director, 16 Apr 2021 to 29 Dec 2022); Monolom India Pharma Private Limited (Director, 20 Nov 2017 to 29 Dec 2022).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available